As of June 10, 2025, NanoRepro AG (NN6.DE) reports a EV/EBITDA of -0.71.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing NanoRepro AG's EV/EBITDA to Peers
To better understand NanoRepro AG's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
Company | EV/EBITDA |
---|---|
NanoRepro AG (NN6.DE) | -0.71 |
Biocorp Production SA (ALCOR.PA) | 4335.46 |
Sectra AB (SECT B.ST) | 76.57 |
Surgical Science Sweden AB (SUS.ST) | 38.01 |
C Rad AB (CRAD B.ST) | 16.29 |
SDI Group PLC (SDI.L) | 7.28 |
Compared to its competitors, NanoRepro AG's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.